Mounds View, MN, United States of America

David Largaespada

This inventor holds 10 USPTO granted patents and 5 published patent applications and 2 EPO patents. Top assignees: B-Mogen Biotechnologies, Inc., Intima Bioscience, Inc., Regents of the University of Minnesota. Active years: 2019-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: David Largaespada. Retrieved from https://idiyas.com/inventor/david-largaespada

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 10 (Patent Applications = 5)

% Patents Active = 100.0

EPO Patents = 2 (Patent Applications = 6)

Average Co-Inventor Count = 6.2

ph-index = 2

Forward Citations = 13(Granted Patents)

Location History:

Minneapolis, MN (US) (2023)
Mounds View, MN (US) (2019 - 2024)

Company Filing History:

4 out of 4

B-Mogen Biotechnologies, Inc.

patents

3 out of 15

Intima Bioscience, Inc.

patents

3 out of 2,369

Regents of the University of Minnesota

patents

4. 3 out of 3,693

The United States of America, as Represented by the Secretary, Department of Health and Human Services

6. 1 out of 834,453

Other

patents

where one patent can have more than one assignee

Years Active: 2019-2024

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12097220 - Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods (2024-09-24),

2. 12037611 - Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods (2024-07-16),

3. 11925664 - Intracellular genomic transplant and methods of therapy (2024-03-12),

4. 11760983 - Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods (2023-09-19),

5. 11583556 - Modified cells and methods of therapy (2023-02-21),

6. 11278570 - Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods (2022-03-22),

7. 11162084 - Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods (2021-11-02),

8. 11147837 - Modified cells and methods of therapy (2021-10-19),

9. 11111483 - Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems and methods (2021-09-07),

10. 10227574 - Enhanced hAT family transposon-mediated gene transfer and associated compositions, systems, and methods (2019-03-12),

Title: The Innovative Journey of David Largaespada

Introduction: David Largaespada, a distinguished inventor hailing from Mounds View, MN (US), has made significant contributions to the field of innovation with his groundbreaking work.

Latest Patents: David Largaespada holds several patents in the realm of biotechnology and genetic research, focusing on novel methods for gene editing and disease treatment.

Career Highlights: With a career spanning over two decades, David Largaespada has been at the forefront of cutting-edge research, leading teams in developing revolutionary technologies that have the potential to transform healthcare and beyond.

Collaborations: Throughout his career, David Largaespada has collaborated with top research institutions, universities, and biotech companies, pooling expertise to drive forward innovative projects and bring new ideas to life.

Conclusion: David Largaespada's passion for innovation and his relentless pursuit of scientific excellence continue to inspire the next generation of inventors and researchers, leaving an indelible mark on the world of technology and discovery.

Profile summary based on public USPTO records.